UNOMR AG
PrivateLast Round
Pre Seed
Feb 27, 2026
Total Funding Raised
$507,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
UNOMR AG operates in Healthcare & Life Sciences and is based in Zurich. Its latest recorded funding round was a Pre Seed round in February 2026.
UNOMR AG is a biotechnology company developing a single-molecule protein analysis platform based on nanopore technology for the life sciences industry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Sensors
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
UNOMR AG Comparables
Compare UNOMR AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Primary Bioscience | 84% | |
| Erisyon | 81% | |
| Glyphic Biotechnologies | 79% |
For institutional investors. Book with your work email.
UNOMR AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Feb 27, 2026 | ||||
| Grant | Jan 5, 2026 | ||||
| Grant | Apr 15, 2025 | ||||
| Grant | Feb 20, 2025 | ||||
| Grant | Dec 16, 2024 | ||||
Grant | Apr 1, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
UNOMR AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gebert Rüf Stiftung | Grant |
| Innosuisse | Grant |
| BRIDGE | Grant |
| Venture Kick | Grant |
| SPRIND | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 99% MoM.
- Aug 18, 2026
Grew 50% QoQ, from 6 to 9 employees.
For institutional investors. Book with your work email.
UNOMR AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about UNOMR AG's valuation, stock price, and market status.
Is UNOMR AG a public or private company?
UNOMR AG is a private company.
What is the current stock price of UNOMR AG?
UNOMR AG is a private company, so its shares have no public market price. Caplight tracks UNOMR AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is UNOMR AG worth (valuation)?
Valuation information for UNOMR AG is not publicly available.
Can I buy UNOMR AG stock?
UNOMR AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was UNOMR AG's last funding round?
UNOMR AG's most recent funding round was Pre Seed on February 27, 2026.
Who are the main investors in UNOMR AG?
Key investors in UNOMR AG include Gebert Rüf Stiftung, Innosuisse, BRIDGE, Venture Kick, SPRIND.
Will UNOMR AG IPO soon?
No public IPO plans have been announced for UNOMR AG.
How can I track UNOMR AG secondary market activity?
Caplight tracks bids, offers, and trades in UNOMR AG's shares on secondary markets.